Our study reveals that the LGR4–Wnt signaling pathway dictates both ferroptosis and stemness traits to confer drug resistance to tumor cells. We thus generated a monoclonal antibody against LGR4 that blocks LGR4–Wnt signaling and sensitizes chemotherapy-resistant colorectal cancer tumors via selective promotion of ferroptosis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ciardiello, F. et al. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J. Clin. 72, 372–401 (2022). This review article presents advances in the clinical management of patients with CRC.
Takebe, N. et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat. Rev. Clin. Oncol. 12, 445–464 (2015). This review article presents important signaling pathways that regulate cancer stem cells and embryonic development.
Cheng, Q. et al. LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis. Cancer Lett. 540, 215725 (2022). This paper reports that CRC tumor cells with high expression of LGR4 and PrPc show all the traits of cancer stem cells.
Guo, J. et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res. Treat. 50, 445–460 (2018). This paper reports that clinical chemotherapy drugs induce ferroptosis in cancer cells.
Friedmann Angeli, J. P., Krysko, D. V. & Conrad, M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405–414 (2019). This review article presents important mechanisms adopted by cancers with acquired drug resistance to provide protection against vulnerability to ferroptosis.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Zheng, H. et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat. Cancer https://doi.org/10.1038/s43018-023-00715-8 (2024).
Rights and permissions
About this article
Cite this article
Targeting LGR4–Wnt activates ferroptosis and reverses drug resistance in colorectal cancer. Nat Cancer 5, 542–543 (2024). https://doi.org/10.1038/s43018-023-00714-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-023-00714-9
